ADGRL1
protein-codingadhesion G protein-coupled receptor L1, the group of Adhesion G protein-coupled receptors, subfamily L
Gene summary
This gene encodes a member of the latrophilin subfamily of G-protein coupled receptors (GPCR). Latrophilins may function in both cell adhesion and signal transduction. In experiments with non-human species, endogenous proteolytic cleavage within a cysteine-rich GPS (G-protein-coupled-receptor proteolysis site) domain resulted in two subunits (a large extracellular N-terminal cell adhesion subunit and a subunit with substantial similarity to the secretin/calcitonin family of GPCRs) being non-covalently bound at the cell membrane. Latrophilin-1 has been shown to recruit the neurotoxin from black widow spider venom, alpha-latrotoxin, to the synapse plasma membrane. Alternative splicing results in multiple variants encoding distinct isoforms.[provided by RefSeq, Oct 2008]
- LPHN1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~58.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: ClinGen
*ADGRL1* encodes an adhesion G protein-coupled receptor, also known as latrophilin 1, which has been implicated in synaptic development, maturation, and activity. *ADGRL1* was first reported in relation to autosomal dominant complex neurodevelopmental disorder in 2022 (Vitobello et al., PMID: 35907405). Clinical features observed in affected individuals include developmental delay, variable intellectual disability, autism spectrum disorder, attention-deficit/hyperactivity disorder, hypotonia, sleep disturbances, and mild facial dysmorphism. Less common findings include macrocephaly, overweight, joint hypermobility, and seizures. Thirteen variants (missense, nonsense, and frameshift) that have been reported in 8 probands in 1 publication (PMID: 35907405) and in 5 clinical laboratory submissions to ClinVar are included in this curation. In cases where parental testing was performed, the variants occurred *de novo*, except for 1 nonsense variant present in 2 affected siblings and inherited from the father with intellectual disability. *ADGRL1* is highly constrained for loss-of-function variants (pLI = 1, LOEUF = 0.28, gnomAD v4.1.1) and missense variants (Z score = 5.05). The mechanism of pathogenicity is reported to be loss of function (PMID: 35907405). This gene-disease relationship is also supported by experiments in cultured neurons showing that Adgrl1 is essential for the assembly of inhibitory synapses (PMID: 38684366). In summary, there is definitive evidence to support the relationship between *ADGRL1* and autosomal dominant complex neurodevelopmental disorder. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on April 15, 2026 (SOP Version 12).
Inheritance Pattern: AD
Disease ID:MONDO:0859292
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0859292
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ADGRL1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_014921.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 39 | 1 | 42 | ||
| missense | 3 | 3 | 251 | 20 | 277 | |
| nonsense | 7 | 6 | 2 | 15 | ||
| start loss | 0 | |||||
| frameshift | 7 | 5 | 2 | 14 | ||
| splice donor/acceptor (+/-2bp) | 3 | 8 | 11 | |||
| Total | 17 | 17 | 265 | 59 | 1 | 359 |
Highest pathogenic variant AF is 0.000003420726
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055736.2 | 22 | MANE Select | |
| Ensembl | ENSP00000355328.2 | 22 | MANE Select | |
| RefSeq | NP_001008701.1 | 23 | Standard | |
| Ensembl | ENSP00000340688.5 | 23 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- GPCRs, Class B Secretin-like
Biological Process
- heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules
- cell surface receptor signaling pathway
- G protein-coupled receptor signaling pathway
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
- calcium-mediated signaling using intracellular calcium source
Molecular Function
- G protein-coupled receptor activity
- protein binding
- latrotoxin receptor activity
- carbohydrate binding
- cell adhesion molecule binding
Cellular Component
- plasma membrane
- integral component of plasma membrane
- postsynaptic density
- integral component of membrane
- cell junction
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000340736
- Coding exons
- 23
- Length
- 56250
- Individuals with no LoFs
- 125738
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 10
- Defined
- 125748
- p
- 0.0000398
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.43 | 640 | 935 | 0.685 | 0.0000651 | 9410 |
| Missense (PolyPhen) | 235 | 433.4 | 0.54222 | 4243 | ||
| Synonymous | -1.72 | 470 | 425 | 1.11 | 0.0000323 | 3087 |
| Loss of Function | 6.99 | 7 | 70.3 | 0.0996 | 0.00000411 | 695 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000036 | 0.000035 | rare |
| South Asian | 0.000035 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Calcium-independent receptor of high affinity for alpha- latrotoxin, an excitatory neurotoxin present in black widow spider venom which triggers massive exocytosis from neurons and neuroendocrine cells. Receptor for TENM2 that mediates heterophilic synaptic cell-cell contact and postsynaptic specialization. Receptor probably implicated in the regulation of exocytosis (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.231
Intolerance Scores
- RVIS EVS
- -2.63
- RVIS percentile EVS
- 0.8
Essentials
- Essential (gene trap)
- N